AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
A PHASE-II STUDY OF NEOADJUVANT CHEMOTHERAPY WITH CISPLATIN, EPIRUBICIN AND VP-16 FOR STAGE-III UNRESECTABLE NONSMALL CELL LUNG-CANCER
Authors: IACOBELLI S IRTELLI L SACCO R MARTINO M MASCITELLI E BASILICO L SCOGNAMIGLIO M NATOLI C FUSCO O TINARI N BELTRAMI V
Citation: S. Iacobelli et al., A PHASE-II STUDY OF NEOADJUVANT CHEMOTHERAPY WITH CISPLATIN, EPIRUBICIN AND VP-16 FOR STAGE-III UNRESECTABLE NONSMALL CELL LUNG-CANCER, Anticancer research, 18(3B), 1998, pp. 2081-2084
90K (MAC-2 BP) GENE-EXPRESSION IN BREAST-CANCER AND EVIDENCE FOR THE PRODUCTION OF 90K BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS
Authors: FUSCO O QUERZOLI P NENCI I NATOLI C BRAKEBUSH C ULLRICH A IACOBELLI S
Citation: O. Fusco et al., 90K (MAC-2 BP) GENE-EXPRESSION IN BREAST-CANCER AND EVIDENCE FOR THE PRODUCTION OF 90K BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS, International journal of cancer, 79(1), 1998, pp. 23-26
DIFFERENTIAL EFFECT ON TCR-CD3 STIMULATION OF A 90-KD GLYCOPROTEIN (GP90 MAC-2BP), A MEMBER OF THE SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN PROTEIN FAMILY/
Authors: SILVESTRI B CALDERAZZO F COPPOLA V ROSATO A IACOBELLI S NATOLI C ULLRICH A SURES I AZAM M BRAKEBUSH C CHIECOBIANCHI L AMADORI A
Citation: B. Silvestri et al., DIFFERENTIAL EFFECT ON TCR-CD3 STIMULATION OF A 90-KD GLYCOPROTEIN (GP90 MAC-2BP), A MEMBER OF THE SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN PROTEIN FAMILY/, Clinical and experimental immunology, 113(3), 1998, pp. 394-400
90K (MAC-2 BP) PREDICTS CD4 DECLINE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH CD4 COUNTS ABOVE 200 X 10(6) CELLS L/
Authors: TINARI N NATOLI C DOSTILIO N GHINELLI F SIGHINOLFI L ORTONA L TAMBURRINI E PIAZZA M CHIRIANNI A GUERRA L DIGREGORIO P IACOBELLI S
Citation: N. Tinari et al., 90K (MAC-2 BP) PREDICTS CD4 DECLINE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH CD4 COUNTS ABOVE 200 X 10(6) CELLS L/, Archives of pathology and laboratory medicine, 122(2), 1998, pp. 178-181
RETREATMENT OR RELAPSERS WITH CHRONIC HEPATITIS-C - THE EFFECT OF DOSE DOUBLING AND OF HOST AND VIRAL FACTORS
Authors: ALMASIO P DIMARCO V BONURA C FUSCHI P CAMMA C LOIACONO O ARTINI M NATOLI C DISTEFANO R LEVRERO M CRAXI A
Citation: P. Almasio et al., RETREATMENT OR RELAPSERS WITH CHRONIC HEPATITIS-C - THE EFFECT OF DOSE DOUBLING AND OF HOST AND VIRAL FACTORS, Hepatology, 26(4), 1997, pp. 1149-1149
TOGLIATTI,PALMIRO - ITALIAN - AGOSTI,A
Authors: NATOLI C
Citation: C. Natoli, TOGLIATTI,PALMIRO - ITALIAN - AGOSTI,A, Studi storici, 38(4), 1997, pp. 1179-1193
A FLOW CYTOMETRIC STUDY OF EARLY GASTRIC-CANCER - THE DETECTION OF HIGH PROLIFERATIVE ACTIVITY ADDS IMPORTANT INFORMATION TO THE PROGNOSIS
Authors: RANALDI R SANTINELLI A FABRIS G MANNELLO B NATOLI C TINARI N BEARZI I
Citation: R. Ranaldi et al., A FLOW CYTOMETRIC STUDY OF EARLY GASTRIC-CANCER - THE DETECTION OF HIGH PROLIFERATIVE ACTIVITY ADDS IMPORTANT INFORMATION TO THE PROGNOSIS, Pathology research and practice, 192(12), 1996, pp. 1202-1205
TUMOR-ASSOCIATED ANTIGEN 90K ACTIVATES MYELOMONOCYTIC CELL-LINE THP-1
Authors: ALTINDAG ZZ MARTH C WERNERFELMAYER G NATOLI C ZEIMET AG WACHTER H IACOBELLI S FUCHS D
Citation: Zz. Altindag et al., TUMOR-ASSOCIATED ANTIGEN 90K ACTIVATES MYELOMONOCYTIC CELL-LINE THP-1, Cancer letters, 107(1), 1996, pp. 143-148
VIREMIA, HCV GENOTYPE AND 90K MAC-2BP LEVELS AS PREDICTORS OF RESPONSE TO A-IFN THERAPY/
Authors: ARTINI M NATOLI C COSTANZO A GRASSADONIA A PORCARI P DEGIDIO M TINARI N BALSANO C PAROLI M IACOBELLI S LEVRERO M
Citation: M. Artini et al., VIREMIA, HCV GENOTYPE AND 90K MAC-2BP LEVELS AS PREDICTORS OF RESPONSE TO A-IFN THERAPY/, Hepatology, 24(4), 1996, pp. 143-143
A PHASE-I STUDY OF 5-DAY CONTINUOUS VENOUS INFUSION OF CARBOPLATIN ATCIRCADIAN RHYTHM-MODULATED RATE COMPARED WITH CONSTANT RATE
Authors: NATOLI C SALINI V IRTELLI L MARTINO MT GARUFI C GRASSADONIA A FIORENTINO B IACOBELLI S
Citation: C. Natoli et al., A PHASE-I STUDY OF 5-DAY CONTINUOUS VENOUS INFUSION OF CARBOPLATIN ATCIRCADIAN RHYTHM-MODULATED RATE COMPARED WITH CONSTANT RATE, Anticancer research, 16(3A), 1996, pp. 1275-1279
ELEVATED SERUM LEVELS OF 90K MAC-2 BP PREDICT UNRESPONSIVENESS TO ALPHA-INTERFERON THERAPY IN CHRONIC HCV HEPATITIS PATIENTS/
Authors: ARTINI M NATOLI C TINARI N COSTANZO A MARINELLI R BALSANO C PORCARI P ANGELUCCI D DEGIDIO M LEVRERO M IACOBELLI S
Citation: M. Artini et al., ELEVATED SERUM LEVELS OF 90K MAC-2 BP PREDICT UNRESPONSIVENESS TO ALPHA-INTERFERON THERAPY IN CHRONIC HCV HEPATITIS PATIENTS/, Journal of hepatology, 25(2), 1996, pp. 212-217
MISIANO,FRANCESCO AND INTERNATIONAL-WORKE RS-RELIEF
Authors: NATOLI C
Citation: C. Natoli, MISIANO,FRANCESCO AND INTERNATIONAL-WORKE RS-RELIEF, Studi storici, 37(4), 1996, pp. 1227-1255
CIRCULATING IMMUNOSTIMULATORY PROTEIN 90K AND SOLUBLE INTERLEUKIN-2-RECEPTOR IN HUMAN OVARIAN-CANCER
Authors: ZEIMET AG NATOLI C HEROLD M FUCHS D WINDBICHLER G DAXENBICHLER G IACOBELLI S DAPUNT O MARTH C
Citation: Ag. Zeimet et al., CIRCULATING IMMUNOSTIMULATORY PROTEIN 90K AND SOLUBLE INTERLEUKIN-2-RECEPTOR IN HUMAN OVARIAN-CANCER, International journal of cancer, 68(1), 1996, pp. 34-38
90K (MAC-2 BP) IN HUMAN-MILK
Authors: DOSTILIO N SABATINO G NATOLI C ULLRICH A IACOBELLI S
Citation: N. Dostilio et al., 90K (MAC-2 BP) IN HUMAN-MILK, Clinical and experimental immunology, 104(3), 1996, pp. 543-546
THE IMMUNE STIMULATORY PROTEIN 90K INCREASES MAJOR HISTOCOMPATIBILITYCOMPLEX CLASS-I EXPRESSION IN A HUMAN BREAST-CANCER CELL-LINE
Authors: NATOLI C IACOBELLI S KOHN L
Citation: C. Natoli et al., THE IMMUNE STIMULATORY PROTEIN 90K INCREASES MAJOR HISTOCOMPATIBILITYCOMPLEX CLASS-I EXPRESSION IN A HUMAN BREAST-CANCER CELL-LINE, Biochemical and biophysical research communications, 225(2), 1996, pp. 617-620
THE 90K TUMOR-ASSOCIATED ANTIGEN AND CLINICAL PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: IACOBELLI S ULLRICH A TINARI N ORTONA L TAMBURRINI E DEGIDIO M GHINELLI F SIGHINOLFI L PIAZZA M CHIRIANNI A GUERRA L NATOLI C
Citation: S. Iacobelli et al., THE 90K TUMOR-ASSOCIATED ANTIGEN AND CLINICAL PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 10(4), 1995, pp. 450-456
A PHASE-I STUDY OF RECOMBINANT INTERFERON-ALPHA ADMINISTERED AS A 7-DAY CONTINUOUS VENOUS INFUSION AT CIRCADIAN-RHYTHM MODULATED RATE IN PATIENTS WITH CANCER
Authors: IACOBELLI S GARUFI C IRTELLI L MARTINO MT SANTOBUONO F VICARIO G TINARI N FIORENTINO B INNOCENTI P NATOLI C
Citation: S. Iacobelli et al., A PHASE-I STUDY OF RECOMBINANT INTERFERON-ALPHA ADMINISTERED AS A 7-DAY CONTINUOUS VENOUS INFUSION AT CIRCADIAN-RHYTHM MODULATED RATE IN PATIENTS WITH CANCER, American journal of clinical oncology, 18(1), 1995, pp. 27-31
HCV GENOTYPE AND SERUM 90K LEVELS - HOST AND VIRUS-RELATED FACTORS PREDICT RESPONSE TO A-IFN THERAPY
Authors: ARTINI M NATOLI C COSTANZO A TINARI N MARINELLI R ANGELUCCI D DEGIDIO M BALSANO C NATOLI G IACOBELLI S LEVRERO M
Citation: M. Artini et al., HCV GENOTYPE AND SERUM 90K LEVELS - HOST AND VIRUS-RELATED FACTORS PREDICT RESPONSE TO A-IFN THERAPY, Hepatology, 22(4), 1995, pp. 276-276
CHRONOMODULATED INFUSION OF 5-FLUOROURACIL, FOLINIC ACID AND CARBOPLATIN IN COLORECTAL-CANCER - A PILOT-STUDY
Authors: NATOLI C MARTINO MT IRTELLI L DOSTILIO N BASILICO L IACOBELLI S
Citation: C. Natoli et al., CHRONOMODULATED INFUSION OF 5-FLUOROURACIL, FOLINIC ACID AND CARBOPLATIN IN COLORECTAL-CANCER - A PILOT-STUDY, Anticancer research, 15(6B), 1995, pp. 2841-2842
GRAMSCI,ANTONIO IN PRISON - CAMPAIGNS TO FREE HIM, THE ITALIAN COMMUNIST-PARTY, THE INTERNATIONALE
Authors: NATOLI C
Citation: C. Natoli, GRAMSCI,ANTONIO IN PRISON - CAMPAIGNS TO FREE HIM, THE ITALIAN COMMUNIST-PARTY, THE INTERNATIONALE, Studi storici, 36(2), 1995, pp. 295-352
EXPRESSION OF TUMOR-ASSOCIATED 90K-ANTIGEN IN HUMAN BREAST-CANCER - NO CORRELATION WITH PROGNOSIS AND RESPONSE TO FIRST-LINE THERAPY WITH TAMOXIFEN
Authors: FOEKENS JA KLIJN JGM NATOLI C VANPUTTEN WLJ DISTEFANO P LOOK MP PORTENGEN H IACOBELLI S
Citation: Ja. Foekens et al., EXPRESSION OF TUMOR-ASSOCIATED 90K-ANTIGEN IN HUMAN BREAST-CANCER - NO CORRELATION WITH PROGNOSIS AND RESPONSE TO FIRST-LINE THERAPY WITH TAMOXIFEN, International journal of cancer, 64(2), 1995, pp. 130-134
PANCREATIC-JUICE 90K AND SERUM CA-19-9 COMBINED DETERMINATION CAN DISCRIMINATE BETWEEN PANCREATIC-CANCER AND CHRONIC-PANCREATITIS
Authors: GENTILONI N CARADONNA P COSTAMAGNA G DOSTILIO N PERRI V MUTIGNANI M FEBBRARO S TINARI N IACOBELLI S NATOLI C
Citation: N. Gentiloni et al., PANCREATIC-JUICE 90K AND SERUM CA-19-9 COMBINED DETERMINATION CAN DISCRIMINATE BETWEEN PANCREATIC-CANCER AND CHRONIC-PANCREATITIS, The American journal of gastroenterology, 90(7), 1995, pp. 1069-1072
90K IS A SERUM MARKER OF POOR-PROGNOSIS IN NON-HODGKINS-LYMPHOMA PATIENTS
Authors: REA A PALMIERI G TINARI N NATOLI C TAGLIAFERRI P MORABITO A GRASSADONIA A BIANCO AR IACOBELLI S
Citation: A. Rea et al., 90K IS A SERUM MARKER OF POOR-PROGNOSIS IN NON-HODGKINS-LYMPHOMA PATIENTS, Oncology Reports, 1(4), 1994, pp. 723-725
IRON STATUS IN SCHIZOPHRENIC-PATIENTS WITH ACUTE NEUROLEPTIC-INDUCED DYSTONIC REACTIONS
Authors: SPINA E ANCIONE M DIROSA AE ARTEMISIA A NATOLI C CAPUTI AP
Citation: E. Spina et al., IRON STATUS IN SCHIZOPHRENIC-PATIENTS WITH ACUTE NEUROLEPTIC-INDUCED DYSTONIC REACTIONS, Progress in neuro-psychopharmacology & biological psychiatry, 18(5), 1994, pp. 891-898
ELEVATED SERUM LEVELS OF A 90,000-DALTONS TUMOR-ASSOCIATED ANTIGEN INCANCER AND IN INFECTION BY HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)
Authors: NATOLI C ORTONA L TAMBURRINI E TINARI N DISTEFANO P DEGIDIO M GHINELLI F SIGHINOLFI L DOSTILIO N PIAZZA M GRASSADONIA A IACOBELLI D IACOBELLI S
Citation: C. Natoli et al., ELEVATED SERUM LEVELS OF A 90,000-DALTONS TUMOR-ASSOCIATED ANTIGEN INCANCER AND IN INFECTION BY HUMAN-IMMUNODEFICIENCY-VIRUS (HIV), Anticancer research, 14(3B), 1994, pp. 1457-1460
Risultati: 1-25 | 26-36